Everything you need to know about the Global Clinical Trial Abundance Survey
This is an independent research initiative measuring public support for accelerating medical progress through pragmatic clinical trials. Your participation helps researchers understand how people prioritize healthcare innovation and clinical research.
This survey is conducted by independent researchers studying healthcare policy and clinical trial methods. The research is designed to be neutral and non-partisan, focusing solely on understanding public attitudes toward medical research acceleration.
All survey responses are anonymous and analyzed in aggregate. Results help researchers understand public support for clinical trial reform and medical research acceleration. Individual responses are never shared or published.
Pragmatic trials test treatments in real-world healthcare settings using existing medical records and routine care, rather than creating expensive artificial research environments. Patients receive normal care while data is automatically collected, making trials 82x cheaper than traditional methods.
Traditional trials cost $20B+ in recruitment, $15B in manual data collection, $10B in dedicated research sites, and $5B in regulatory overhead. Pragmatic trials eliminate these costs by using existing healthcare infrastructure, electronic health records, and streamlined protocols. Total savings: $58.6B annually.
Yes. They follow the same scientific principles and regulatory standards. The difference is efficiency, not rigor. Oxford's RECOVERY trial (pragmatic design) enrolled 40,000 patients in months and found effective COVID treatments while traditional trials were still recruiting. Same safety, 82x faster and cheaper.
Everything: new drugs, repurposed existing medications, medical devices, surgical techniques, behavioral interventions, prevention strategies. Pragmatic trials excel at comparing real-world effectiveness of treatments, finding optimal doses, and identifying which patients benefit most.
Immediate impact. Pragmatic trials can begin enrolling patients within weeks of approval. Results for acute conditions (like COVID treatments) can come in months. Chronic disease trials take longer but still deliver answers years faster than traditional methods.
Most participants complete the survey in 2-5 minutes. There are no right or wrong answers – we simply want to understand your views on medical research priorities.
Yes. The survey can be completed without providing any personal information. If you choose to create an account, your contact information is kept separate from your survey responses.